Physician profile
Cynthia G Bindner
NPI 1942273420
$1,559.78
in general payments reported to CMS, 2019-2025
21 companies · $129 in 2025
The $129 reported for 2025 was less than what a typical Obstetrics & Gynecology provider received nationally (typical 2025 total: $158).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2019: $120 · 2020: $214 · 2021: $329 · 2022: $462 · 2023: $200 · 2024: $106 · 2025: $129.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $435.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $435.29 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Abbvie INC. | $692.77 | 2019-2023 | Lo Loestrin Fe, Orilissa, Liletta |
| Hologic Sales and Service, LLC | $149.41 | 2019-2025 | Aptima, Thinprep 2000 Processor |
| Organon LLC | $101.29 | 2021-2023 | Nexplanon |
| Optumhealth Care Solutions, LLC | $69.46 | 2024 | Eitan Medical, Vivify Health Care Team Portal 001 |
| Daiichi Sankyo INC. | $62.67 | 2021-2024 | Injectafer |
| Scynexis, INC. | $58.10 | 2022 | |
| Bayer Healthcare Pharmaceuticals INC. | $57.72 | 2022-2024 | |
| Pfizer INC. | $57.16 | 2020-2022 | |
| Myovant Sciences INC. | $51.99 | 2022 | |
| Merck Sharp & Dohme LLC | $34.22 | 2020-2021 | |
| Mayne Pharma Commercial LLC | $33.20 | 2025 | |
| Amgen INC. | $30.21 | 2022-2023 | Prolia, Evenity |
| Astellas Pharma US INC | $27.26 | 2025 | Veozah |
| Duchesnay USA Incorporated | $24.79 | 2019 | |
| Exact Sciences Corporation | $20.16 | 2025 | Cologuard Collection Kit |
Show all 21 companies
| Company | General payments | Years | Top products |
|---|---|---|---|
| Baxter Healthcare | $18.56 | 2023 | Floseal |
| Intra-Sana Laboratories | $17.11 | 2025 | Glycate, Reltone 200 Mg, Reltone 400 Mg |
| Urovant Sciences INC | $15.21 | 2022 | |
| Therapeuticsmd, INC. | $13.49 | 2021 | |
| Avion Pharmaceuticals | $13.14 | 2021 | |
| Channel Medsystems, INC. | $11.86 | 2022 |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Cynthia G Bindner listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.